Status:

TERMINATED

VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients.

Lead Sponsor:

Centre Hospitalier Universitaire de Saint Etienne

Collaborating Sponsors:

Gustave Roussy, Cancer Campus, Grand Paris

Centre Antoine Lacassagne

Conditions:

Endometrial Cancer

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

This randomized phase III multicenter trial aims to evaluate the impact of virtual reality helmets (visual and audio) during VCB in patients treated for endometrial cancer, in terms of pain and anxiet...

Detailed Description

Endometrial cancer is one of the most common gynaecological cancers among women in the developed countries. After a curative surgical treatment, many relapses occur in the vaginal cuff. The PORTEC-2 t...

Eligibility Criteria

Inclusion

  • Patients over 18 years old.
  • Patients with endometrial cancer, with histological type I and II, regardless of the degree of differentiation.
  • Patients with stage I, II or III endometrial cancer according to the FIGO classification.
  • Patients treated with high-dose-rate vaginal cuff brachytherapy, with curative intent.
  • Patients affiliated or entitled to a social security scheme.
  • Patients who received information about the study and co-signed with the investigator the consent to participate at the study.

Exclusion

  • Patients with stage IV endometrial cancer according to FIGO classification.
  • Patients presenting recurrence of endometrial cancer.
  • Pregnant or nursing women.
  • Patients under protection of justice or unable to give consent.

Key Trial Info

Start Date :

March 26 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 4 2021

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT03324958

Start Date

March 26 2019

End Date

March 4 2021

Last Update

February 8 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Institut de Cancérologie Lucien Neuwirth

Saint-Priest-en-Jarez, France, 42270

2

Institut Gustave Roussy

Villejuif, France, 94805